BioDiversitX

Industrialized Herbal Medicines and the Medical Cannabis Sector BioDiversitX will bring together experts and key stakeholders to discuss Brazil’s latest regulatory advances, new rules for the regularization of herbal medicines and medical cannabis, and opportunities arising from international regulatory harmonization. Representatives from Anvisa (Brazil’s National Health Surveillance Agency) and the Brazilian Ministry of Health will present the latest regulatory frameworks and their implications for the sector. The discussions will also explore opportunities to strengthen Brazil’s national production chain, add value to its biodiversity, foster innovation, and expand access to international markets. Join us for this strategic discussion on regulation, biodiversity, innovation, and international opportunities.